Modeling boundary conditions for balanced proliferation in metastatic latency

Clinical Cancer Research

Volumn 19, Issue 5, 2013, Pages 1063-1070

  Taylor, Donald P ^a   Wells, Jakob Z ^b   Savol, Andrej ^a   Chennubhotla, Chakra ^a   Wells, Alan ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b Taylor Allderdice High School   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CELL COUNT; CELL DEATH; CELL POPULATION; CELL PROLIFERATION; CELL SURVIVAL; COMPUTER MODEL; DORMANCY; MATHEMATICAL MODEL; METASTASIS POTENTIAL; MICROMETASTASIS; MONTE CARLO METHOD; PRIORITY JOURNAL; PROBABILITY; STOCHASTIC MODEL;

ANIMALS; APOPTOSIS; CELL PROLIFERATION; COMPUTER SIMULATION; HUMANS; MARKOV CHAINS; MODELS, BIOLOGICAL; MONTE CARLO METHOD; NEOPLASM METASTASIS; NEOPLASMS;

EID: 84874908195     PISSN: 10780432     EISSN: 15573265     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-12-3180     Document Type: Article

References (27)

1. Naumov GN, MacDonald IC, Weinmeister PM, Kerkvliet N, Nadkarni KV, Wilson SM, et al. Persistence of solitary mammary carcinoma cells in a secondary site: a possible contributor to dormancy. Cancer Res 2002;62: 2162-8.
2. Aguirre-Ghiso JA. Models, mechanisms and clinical evidence for cancer dormancy. Nat Rev Cancer 2007;7: 834-46.
3. Fisher B, Anderson S, Bryant J, Margolese RG, Deutsch M, Fisher ER, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 2002;347: 1233-41.
4. Townson JL, Chambers AF. Dormancy of solitary metastatic cells. Cell Cycle 2006;5: 1744-50.
5. Aguirre-Ghiso JA. The problem of cancer dormancy: understanding the basic mechanisms and identifying therapeutic opportunities. Cell Cycle 2006;5: 1740-3.
6. Wells A, Yates C, Shepard CR. E-cadherin as an indicator of mesenchymal to epithelial reverting transitions during the metastatic seeding of disseminated carcinomas. Clin Exp Metastasis 2008;25: 621-8.
7. Luzzi KJ, MacDonald IC, Schmidt EE, Kerkvliet N, Morris VL, Chambers AF, et al. Multistep nature of metastatic inefficiency: dormancy of solitary cells after successful extravasation and limited survival of early micrometastases. Am J Pathol 1998;153: 865-73.
8. Mocellin S, Hoon D, Ambrosi A, Nitti D, Rossi CR. The prognostic value of circulating tumor cells in patients with melanoma: a systematic review and meta-analysis. Clin Cancer Res 2006;12: 4605-13.
9. Jiao Y, Torquato S. Emergent behaviors from a cellular automaton model for invasive tumor growth in heterogeneous microenvironments. PLoS Comput Biol 2011;7:e1002314.
10. Antal T, Krapivsky PL. Outbreak size distributions in epidermics with multiple stages. J Stat Mech 2012;2012:p07018.
11. LaPorta CAM, Zapperi S, Sethna JP. Senescent cells in growing tumors: population dynamics and cancer stem cells. PLoS Comput Biol 2012;8:e1002316.
12. Willis L, Alarcón T, Elia G, Jones JL, Wright NA, Tomlinson IP, et al. Breast cancer dormancy can be maintained by small numbers of micrometastases. Cancer Res 2010;70: 4310-7.
13. Haustein V, Schumacher U. A dynamic model for tumour growth and metastasis formation. J Clin Bioinforma 2012;2: 11.
14. Haeno H, Michor F. The evolution of tumor metastases during clonal expansion. J Theor Biol 2010;263: 30-44.
15. Naumov GN, Akslen LA, Folkman J. Role of angiogenesis in human tumor dormancy: animal models of the angiogenic switch. Cell Cycle 2006;5: 1779-87.
16. Marshall JC, Collins JW, Nakayama J, Horak CE, Liewehr DJ, Steinberg SM, et al. Effect of inhibition of the lysophosphatidic acid receptor 1 on metastasis and metastatic dormancy in breast cancer. J Natl Cancer Inst 2012;104: 1306-19.
17. Dodds MG, Vicini P. Assessing convergence of Markov chain Monte Carlo simulations in hierarchical Bayesian models for population pharmacokinetics. Ann Biomed Eng 2004;32: 1300-13.
18. Kamiya N, Suzuki H, Endo T, Yano M, Naoi M, Nishimi D, et al. Clinical usefulness of bone markers in prostate cancer with bone metastasis. Int J Urol 2012;19: 968-79.
19. Berman JJ, Moore GW. The role of cell death in the growth of preneoplastic lesions: a Monte Carlo simulation model. Cell Prolif 1992;25: 549-57.
20. Ycart B. Fluctuation analysis with cell deaths. arXiv preprint arXiv 2012: e1207.4375.
21. Michor F, Nowak MA, Iwasa Y. Stochastic dynamics of metastasis formation. J Theor Biol 2006;240: 521-30.
22. Watson HW, Galton F. On the probability of the extinction of families. J Anthropol Inst Great Brit Ireland 1875;4: 138-44.
23. Harris T. The theory of branching processes. United States: Air Force Project RAND;1964: 1-248.
24. Klein CA, Holzel D. Systemic cancer progression and tumor dormancy: mathematical models meet single cell genomics. Cell Cycle 2006;5: 1788-98.
25. Naumov GN, Folkman J, Straume O, Akslen LA. Tumor-vascular interactions and tumor dormancy. APMIS 2008;116: 569-85.
26. Divoli A, Mendonca EA, Evans JA, Rzhetsky A. Conflicting biomedical assumptions for mathematical modeling: the case of cancer metastasis. PLoS Comput Biol 2011;7:e1002132.
27. Bednarz-Knoll N, Alix-Panabieres C, Pantel K. Clinical relevance and biology of circulating tumor cells. Breast Cancer Res 2011;13: 228.